Therapeutic efficacy of fixed dose artesunate-mefloquine for the treatment of acute, uncomplicated Plasmodium falciparum malaria in Kampong Speu, Cambodia

BACKGROUND: Cambodia stopped using co-blistered, non-fixed, artesunate-mefloquine (ASMQ) in 2008 when treatment failure rates approximated 20%. Fixed dose combination (FDC) ASMQ is efficacious against acute uncomplicated, drug resistant Plasmodium falciparum malaria in Southeast Asia but has not bee...

Descripción completa

Detalles Bibliográficos
Autores principales: Leang, Rithea, Ros, Sakun, Duong, Socheat, Navaratnam, Visweswaran, Lim, Pharath, Ariey, Frédéric, Kiechel, Jean-René, Ménard, Didier, Taylor, Walter RJ
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3852322/
https://www.ncbi.nlm.nih.gov/pubmed/24060207
http://dx.doi.org/10.1186/1475-2875-12-343

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3852322/
https://www.ncbi.nlm.nih.gov/pubmed/24060207
http://dx.doi.org/10.1186/1475-2875-12-343

Ejemplares similares